EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin

Abdallah Elnwasany, Heba A Ewida, Ivan Menendez-Montes, Monika Mizerska, Xiaorong Fu, Chai-Wan Kim, Jay D Horton, Shawn C Burgess, Beverly A Rothermel, Pamela A Szweda, Luke I Szweda

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Abdallah Elnwasany und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Insulin, Oxidation-Reduction, Pyruvate Dehydrogenase Complex, Myocardium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heart alters the rate and relative oxidation of fatty acids and glucose based on availability and energetic demand. Insulin plays a crucial role in this process diminishing fatty acid and increasing glucose oxidation when glucose availability increases. Loss of insulin sensitivity and metabolic flexibility can result in cardiovascular disease. It is therefore important to identify mechanisms by which insulin regulates substrate utilization in the heart. Mitochondrial pyruvate dehydrogenase (PDH) is the key regulatory site for the oxidation of glucose for ATP production. Nevertheless, the impact of insulin on PDH activity has not been fully delineated, particularly in the heart. We sought in vivo evidence that insulin stimulates cardiac PDH and that this process is driven by the inhibition of fatty acid oxidation. Mice injected with insulin exhibited dephosphorylation and activation of cardiac PDH. This was accompanied by an increase in the content of malonyl-CoA, an inhibitor of carnitine palmitoyltransferase 1 (CPT1), and, thus, mitochondrial import of fatty acids. Administration of the CPT1 inhibitor oxfenicine was sufficient to activate PDH. Malonyl-CoA is produced by acetyl-CoA carboxylase (ACC). Pharmacologic inhibition or knockout of cardiac ACC diminished insulin-dependent production of malonyl-CoA and activation of PDH. Finally, circulating insulin and cardiac glucose utilization exhibit daily rhythms reflective of nutritional status. We demonstrate that time-of-day-dependent changes in PDH activity are mediated, in part, by ACC-dependent production of malonyl-CoA. Thus, by inhibiting fatty acid oxidation, insulin reciprocally activates PDH. These studies identify potential molecular targets to promote cardiac glucose oxidation and treat heart disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinOxidation-ReductionPyruvate Dehydrogenase ComplexMyocardiumFatty AcidsAnimalsMiceAcetyl-CoA CarboxylaseCarnitine O-PalmitoyltransferaseMalonyl Coenzyme AMaleMice, KnockoutGlucoseMice, Inbred C57BL

Stichwörter der Autor:innen

acetyl-CoA carboxylaseheartinsulinmalonyl-CoAmitochondriapyruvate dehydrogenaseβ-oxidation

Substanzen

InsulinPyruvate Dehydrogenase ComplexFatty AcidsAcetyl-CoA CarboxylaseCarnitine O-PalmitoyltransferaseMalonyl Coenzyme AGlucose

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, USA; Faculty of Pharmacy, Future University in Egypt (FUE), Cairo, Egypt.
  • Department of Pharmacology, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Departments of Internal Medicine and Molecular Genetics, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: luke.szweda@utsouthwestern.edu.

Förderung

  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Elnwasany, A., Ewida, H. A., Menendez-Montes, I., Mizerska, M., Fu, X., Kim, C. W., Horton, J. D., Burgess, S. C., Rothermel, B. A., Szweda, P. A., & Szweda, L. I. (2024). Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107412

Vancouver

Elnwasany A, Ewida HA, Menendez-Montes I, Mizerska M, Fu X, Kim CW, et al. Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107412

BibTeX
@article{Elnwasany2024,
  author = {Elnwasany, Abdallah and Ewida, Heba A and Menendez-Montes, Ivan and Mizerska, Monika and Fu, Xiaorong and Kim, Chai-Wan and Horton, Jay D and Burgess, Shawn C and Rothermel, Beverly A and Szweda, Pamela A and Szweda, Luke I},
  title = {Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107412}
}
Kostenlos starten →